Cameron (CAM) - soon to be bought by Boston Scientific (BSX) - is -2.6% after FDA reviewers say they won't OK the firm's defibrillator until it resolves problems of the battery depleting too quickly. The reviewers also say the product, which is inserted under the skin, may have more infection issues and work slower than similar devices placed in the heart.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Nasdaq.com (Jan 21, 2015)
at Nasdaq.com (Jan 7, 2015)
at Investor's Business Daily (Jan 6, 2015)
at Benzinga.com (Jan 5, 2015)
at Nasdaq.com (Dec 26, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs